{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:22:46Z","timestamp":1792740166865,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1227\/neu.0b013e31825ca05f","type":"journal-article","created":{"date-parts":[[2012,5,5]],"date-time":"2012-05-05T11:53:06Z","timestamp":1336218786000},"page":"405-416","source":"Crossref","is-referenced-by-count":117,"title":["Intraspinal Stem Cell Transplantation in Amyotrophic Lateral Sclerosis"],"prefix":"10.1227","volume":"71","author":[{"given":"Jonathan","family":"Riley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meraida","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethwel","family":"Raore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Kesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Boulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-34-20230406","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimers disease.","volume":"12","author":"Mandel","year":"2010","journal-title":"Curr Opin Mol Ther"},{"issue":"9579","key":"R2-34-20230406","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","article-title":". Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinsons disease: an open label, phase I trial.","volume":"369","author":"Kaplitt","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"R3-34-20230406","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":". Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinsons disease: an open-label, phase I trial.","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol"},{"issue":"11","key":"R4-34-20230406","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1089\/104303402760128612","article-title":". Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.","volume":"13","author":"Janson","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"5","key":"R5-34-20230406","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":". Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"2","key":"R7-34-20230406","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1752-8062.2008.00084.x","article-title":"Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord.","volume":"2","author":"Federici","year":"2009","journal-title":"Clin Transl Sci"},{"issue":"2","key":"R8-34-20230406","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000112426","article-title":". Targeted spinal cord therapeutics delivery: stabilized platform and microelectrode recording guidance validation.","volume":"86","author":"Riley","year":"2008","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"R11-34-20230406","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cne.22022","article-title":"Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry.","volume":"514","author":"Xu","year":"2009","journal-title":"J Comp Neurol"},{"issue":"3","key":"R12-34-20230406","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2011.03.017","article-title":"Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.","volume":"494","author":"Xu","year":"2011","journal-title":"Neurosci Lett"},{"issue":"7","key":"R13-34-20230406","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.tp.0000235532.00920.7a","article-title":". Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats.","volume":"82","author":"Xu","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"R14-34-20230406","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pmed.0040039","article-title":". Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord.","volume":"4","author":"Yan","year":"2007","journal-title":"PLoS Med"},{"issue":"6","key":"R18-34-20230406","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":". Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients.","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"issue":"2","key":"R19-34-20230406","first-page":"673","article-title":"Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.","volume":"5","author":"Nematalla","year":"2007","journal-title":"Exp Clin Transpl"},{"issue":"suppl A","key":"R20-34-20230406","first-page":"31","article-title":". Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial in Spanish.","volume":"32","author":"Blanquer","year":"2010","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"1","key":"R21-34-20230406","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","article-title":". Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial.","volume":"223","author":"Mazzini","year":"2010","journal-title":"Exp Neurol"},{"issue":"10","key":"R22-34-20230406","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":". Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/71\/2\/405\/32587035\/00006123-201208000-00034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201208000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:41:19Z","timestamp":1786120879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201208000-00034"}},"subtitle":["A Phase I Safety Trial, Technical Note, and Lumbar Safety Outcomes"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1227\/neu.0b013e31825ca05f","relation":{},"ISSN":["0148-396X"],"issn-type":[{"value":"0148-396X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}